Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of the Female Reproductive System

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

COF-based electrocatalysts for the hydrogen evolution reaction: construction strategies, performance enhancement, and challenges.

Chemical communications (Cambridge, England)·2026

Same author

Patient-derived model capturing hypoxia and extracellular matrix remodelling of immunologically cold high-grade serous tumours.

Nature communications·2026

Same author

Transient Thermal Engineering of Pt@rGO Nanocatalysts via Oxygen Anchoring and Chlorine Coordination for Efficient Hydrogen Generation.

Small (Weinheim an der Bergstrasse, Germany)·2026

Same author

Newly identified invasion drivers define the tumor front in oral squamous cell carcinoma.

Cell death discovery·2026

Same author

Integrated microfluidic biosensors: shaping the future of quantitative life sciences and on-chip molecular diagnostics.

Lab on a chip·2026

Same author

Hybrid Deep Learning-Machine Learning Fusion of Clinical, Radiomic and Deep Learning Features for Preoperative Differentiation of Solitary Pulmonary Mucinous Adenocarcinoma.

Diagnostics (Basel, Switzerland)·2026

Search research articles

Related Experiment Video

Updated: May 22, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Endometrial cancer.

Kimberly K Leslie¹, Kristina W Thiel, Michael J Goodheart

¹Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USA. kimberly-leslie@uiowa.edu

Obstetrics and Gynecology Clinics of North America

|May 30, 2012

Summary

Molecular therapy shows promise for endometrial cancer treatment, aiming to improve patient outcomes. The best strategy involves managing the disease as chronic and enhancing progression-free survival.

More Related Videos

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Published on: January 26, 2024

Related Experiment Videos

Last Updated: May 22, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Published on: January 26, 2024

Area of Science:

Oncology
Molecular Biology
Gynecologic Oncology

Background:

Endometrial cancer presents challenges in treatment and survival rates.
Current therapeutic strategies have limitations in improving long-term outcomes.
There is a need for innovative approaches to manage endometrial cancer effectively.

Purpose of the Study:

To explore the potential of molecular therapy in endometrial cancer treatment.
To investigate strategies for improving progression-free survival in endometrial cancer patients.
To assess the feasibility of managing endometrial cancer as a chronic condition.

Main Methods:

Review of current literature on molecular therapies for endometrial cancer.
Analysis of treatment regimens incorporating targeted molecular agents.
Evaluation of progression-free survival data in relevant clinical trials.

Main Results:

Molecular therapy integration is a promising area for endometrial cancer.
Managing endometrial cancer as a chronic illness offers a potential survival benefit.
Improved progression-free survival is a key objective for reversing declining survival trends.

Conclusions:

Molecular therapies hold significant potential for advancing endometrial cancer care.
Shifting focus to chronic disease management and progression-free survival is crucial.
Further research is warranted to overcome barriers and optimize molecular therapy incorporation.